genprowebdirectory
Facebook Linkedin RSS Twitter Youtube
  • GEN Edge
    • Featured News
    • Multimedia
  • News
    • Insights
  • Topics
    • Artificial Intelligence
    • Bioprocessing
    • Cancer
    • Drug Discovery
    • Genome Editing
    • Infectious Diseases
    • OMICs
    • Translational Medicine
  • Magazine
    • Browse Issues
    • Subscribe
  • Multimedia
    • Summits
    • Webinars
    • GEN Live
    • Learning Labs
    • Podcasts
  • Resources
    • A-Lists
    • eBooks/Perspectives
    • Tutorials
    • Peer-Reviewed Journals
      • GEN Biotechnology
      • Re:Gen Open
    • New Products
    • Conference Calendar
  • Subscribe
    • Get GEN Magazine
    • Get GEN eNewsletters
Search
Facebook Linkedin RSS Twitter Youtube
Sign in
Welcome! Log into your account
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
A password will be e-mailed to you.
Genetic Engineering & Biotechnology News GEN – Genetic Engineering and Biotechnology News
Genetic Engineering & Biotechnology News Genetic Engineering & Biotechnology News
  • GEN Edge
    • Featured News
    • Multimedia
  • News
    • Insights
  • Topics
    • Artificial Intelligence
    • Bioprocessing
    • Cancer
    • Drug Discovery
    • Genome Editing
    • Infectious Diseases
    • OMICs
    • Translational Medicine
  • Magazine
    • Browse Issues
    • Subscribe
  • Multimedia
    • Summits
    • Webinars
    • GEN Live
    • Learning Labs
    • Podcasts
  • Resources
    • A-Lists
    • eBooks/Perspectives
    • Tutorials
    • Peer-Reviewed Journals
      • GEN Biotechnology
      • Re:Gen Open
    • New Products
    • Conference Calendar
  • Subscribe
    • Get GEN Magazine
    • Get GEN eNewsletters
Home 2024

Hematologic diseases

NGS Panel for Acute Myeloid Leukemia
New Products

NGS Panel for Acute Myeloid Leukemia

Platelet Pathway More Traveled with Age, Leads to Excessive Clotting
Featured

Platelet Pathway More Traveled with Age, Leads to Excessive Clotting

ASGCT 2024: Gene Therapy Delivery and Development Dominates Opening Workshop
Drug Discovery

ASGCT 2024: Gene Therapy Delivery and Development Dominates Opening Workshop

FDA Clears Prime Medicine’s IND for First Prime Editing Therapy
Genome Editing

FDA Clears Prime Medicine’s IND for First Prime Editing Therapy

Uncovering RNA Splicing’s Cell-Specific Impact on Clonal Blood Disorders with GoT-Splice
Cancer

Uncovering RNA Splicing’s Cell-Specific Impact on Clonal Blood Disorders with GoT-Splice

ReciBioPharm Partners with GeneVentiv on AAV-based Gene Therapy for the Treatment of Hemophilia
Bioprocessing

ReciBioPharm Partners with GeneVentiv on AAV-based Gene Therapy for the Treatment of Hemophilia

Improving Flow through the Cell Therapies Bottleneck
Bioprocessing

Improving Flow through the Cell Therapies Bottleneck

Cell and Gene Therapy Manufacturing and Development Trends
Bioprocessing

Cell and Gene Therapy Manufacturing and Development Trends

One-Pot Method for Generating Orally Available Cyclic Peptide Drug Candidates
Drug Discovery

One-Pot Method for Generating Orally Available Cyclic Peptide Drug Candidates

“Transformer” Base Editor Safely and Durably Induces Fetal Hemoglobin in Human HSCs
Genome Editing

“Transformer” Base Editor Safely and Durably Induces Fetal Hemoglobin in Human HSCs

123...28Page 1 of 28

Read the Digital Edition

June 2024 cover

Explore

  • About GEN
  • Contact GEN
  • GEN Staff
  • Editorial Guidelines
  • Reprints and Permissions
  • Scientific Advisory Board

Advertise

  • Media Kit and Planning Calendar
  • Advertising Terms and Conditions

Resources

  • Get the GEN Magazine
  • Get the GEN Email Newsletter
  • Inside Precision Medicine
  • Privacy Policy
Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.
Scroll Up